VERTEX PHARMACEUTICALS INC | 186.38 / +0.14% |
Date/Time | 01/15 / 17:32 |
Chg. / Chg.(%) | 0.26 / +0.14% |
Bid | - |
Ask | - |
Open | 186.02 |
Previous Close | 186.12 |
High | 187.82 |
Low | 186.02 |
Volume [EUR] | 19,828.30 |
Volume [Units] | 106 |
Price fixings | 5 |
ISIN | US92532F1003 |
Security | VRTX |
Exchange | Vienna Global Market |
Type | Stock |
Other Exchanges
Exchange | Last | Volume | |
---|---|---|---|
Lang & Schwa.. | 185.760 | ![]() |
|
NASDAQ | 225.5500 | ![]() |
2,242,187 |
IEX | 225.55 | ![]() |
200,041 |
Cboe US | 225.54 | ![]() |
68,436 |
TradeGate | 186.660 | ![]() |
898 |
London Inter.. | 225.26 | ![]() |
356 |
Frankfurt | 187.1800 | ![]() |
150 |
gettex | 188.100 | ![]() |
116 |
Vienna Globa.. | 186.38 | ![]() |
106 |
Xetra | 186.64 | ![]() |
90 |
Stuttgart | 187.160 | ![]() |
52 |
Berlin | 187.22 | ![]() |
16 |
Mexico | 4,500.00 | ![]() |
7 |
München | 185.02 | ![]() |
0 |
Düsseldorf | 187.56 | ![]() |
0 |
Hannover | 185.02 | ![]() |
0 |
Hamburg | 185.02 | ![]() |
0 |
News
- Kymera Therapeutics Announces Key 2021 Goals and Milestones to Support its Evolution into a Fully Integrated Degrader Medicines Company
01/12/2021 / 13:00 - GlobeNewswire - Spero Therapeutics Announces Appointment of Sath Shukla as Chief Financial Officer
12/17/2020 / 14:00 - GlobeNewswire - Sarepta Therapeutics Announces Executive Management Changes
12/14/2020 / 14:30 - GlobeNewswire - CRISPR Therapeutics Receives Grant to Advance In Vivo CRISPR/Cas9 Gene Editing Therapies for HIV
12/14/2020 / 14:00 - GlobeNewswire - Spero Therapeutics Announces First Patient Dosed with SPR720 in Phase 2a Clinical Trial in Patients with Nontuberculous Mycobacterial Pulmonary Disease
12/10/2020 / 14:00 - GlobeNewswire